Suzhou Chung-Hwa Chemical&Pharmaceutical Wenlening ^® (Telmisartan Hydrochlorothiazide Tablets) was selected in the tenth batch of national drug centralized procurement!

Wenlening ^® (Telmisartan Hydrochlorothiazide Tablets) is a classic single-tablet compound preparation of ARB (Telmisartan) + diuretic (Hydrochlorothiazide), and is a mainstream compound single-tablet preparation recommended by authoritative guidelines at home and abroad. Wenlening ^® (Telmisartan Hydrochlorothiazide Tablets) is available in two specifications: 40mg/12.5mg and 80mg/12.5mg, which can meet the treatment needs of different clinical populations.

Suzhou Chung-Hwa Chemical & Pharmaceutical has always been adhering to the core values of "passion, innovation, care, and health", focusing on quality, insisting on continuous innovation, and constantly improving core competitiveness, and continuously committed to providing more safe, effective, quality-controlled, clinically accessible treatment options and health services for patients. This time, Wenlening ^® (Telmisartan Hydrochlorothiazide Tablets) was selected in the "Ten Selections", providing a new option for antihypertensive solutions for subsequent clinical medication and patients.